91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Small Molecule Drug CDMO Services Market Growth (Status and Outlook) 2024-2030

Global Small Molecule Drug CDMO Services Market Growth (Status and Outlook) 2024-2030

Publication ID: 
LPI04241417
Publication Date: 
April 8, 2024
Pages: 
123
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
The global Small Molecule Drug CDMO Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
publisher' newest research report, the 鈥淪mall Molecule Drug CDMO Services Industry Forecast鈥� looks at past sales and reviews total world Small Molecule Drug CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Small Molecule Drug CDMO Services sales for 2023 through 2029. With Small Molecule Drug CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Drug CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Drug CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Drug CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Small Molecule Drug CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Drug CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Drug CDMO Services.
United States market for Small Molecule Drug CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Small Molecule Drug CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Small Molecule Drug CDMO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Small Molecule Drug CDMO Services players cover Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Drug CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Preparation
Chemical API
Segmentation by Application:
Clinical Treatment
Medical Research
Commercial Production
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Preparation
Chemical API
Segmentation by Application:
Clinical Treatment
Medical Research
Commercial Production
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Drug CDMO Services Market Size 2019-2030
2.1.2 Small Molecule Drug CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Small Molecule Drug CDMO Services by Country/Region, 2019, 2023 & 2030
2.2 Small Molecule Drug CDMO Services Segment by Type
2.2.1 Preparation
2.2.2 Chemical API
2.3 Small Molecule Drug CDMO Services Market Size by Type
2.3.1 Small Molecule Drug CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Small Molecule Drug CDMO Services Market Size Market Share by Type (2019-2024)
2.4 Small Molecule Drug CDMO Services Segment by Application
2.4.1 Clinical Treatment
2.4.2 Medical Research
2.4.3 Commercial Production
2.5 Small Molecule Drug CDMO Services Market Size by Application
2.5.1 Small Molecule Drug CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Small Molecule Drug CDMO Services Market Size Market Share by Application (2019-2024)
3 Small Molecule Drug CDMO Services Market Size by Player
3.1 Small Molecule Drug CDMO Services Market Size Market Share by Player
3.1.1 Global Small Molecule Drug CDMO Services Revenue by Player (2019-2024)
3.1.2 Global Small Molecule Drug CDMO Services Revenue Market Share by Player (2019-2024)
3.2 Global Small Molecule Drug CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Drug CDMO Services by Region
4.1 Small Molecule Drug CDMO Services Market Size by Region (2019-2024)
4.2 Global Small Molecule Drug CDMO Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Small Molecule Drug CDMO Services Market Size Growth (2019-2024)
4.4 APAC Small Molecule Drug CDMO Services Market Size Growth (2019-2024)
4.5 Europe Small Molecule Drug CDMO Services Market Size Growth (2019-2024)
4.6 Middle East & Africa Small Molecule Drug CDMO Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
5.2 Americas Small Molecule Drug CDMO Services Market Size by Type (2019-2024)
5.3 Americas Small Molecule Drug CDMO Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Drug CDMO Services Market Size by Region (2019-2024)
6.2 APAC Small Molecule Drug CDMO Services Market Size by Type (2019-2024)
6.3 APAC Small Molecule Drug CDMO Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Drug CDMO Services Market Size by Country (2019-2024)
7.2 Europe Small Molecule Drug CDMO Services Market Size by Type (2019-2024)
7.3 Europe Small Molecule Drug CDMO Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Drug CDMO Services by Region (2019-2024)
8.2 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule Drug CDMO Services Market Forecast
10.1 Global Small Molecule Drug CDMO Services Forecast by Region (2025-2030)
10.1.1 Global Small Molecule Drug CDMO Services Forecast by Region (2025-2030)
10.1.2 Americas Small Molecule Drug CDMO Services Forecast
10.1.3 APAC Small Molecule Drug CDMO Services Forecast
10.1.4 Europe Small Molecule Drug CDMO Services Forecast
10.1.5 Middle East & Africa Small Molecule Drug CDMO Services Forecast
10.2 Americas Small Molecule Drug CDMO Services Forecast by Country (2025-2030)
10.2.1 United States Market Small Molecule Drug CDMO Services Forecast
10.2.2 Canada Market Small Molecule Drug CDMO Services Forecast
10.2.3 Mexico Market Small Molecule Drug CDMO Services Forecast
10.2.4 Brazil Market Small Molecule Drug CDMO Services Forecast
10.3 APAC Small Molecule Drug CDMO Services Forecast by Region (2025-2030)
10.3.1 China Small Molecule Drug CDMO Services Market Forecast
10.3.2 Japan Market Small Molecule Drug CDMO Services Forecast
10.3.3 Korea Market Small Molecule Drug CDMO Services Forecast
10.3.4 Southeast Asia Market Small Molecule Drug CDMO Services Forecast
10.3.5 India Market Small Molecule Drug CDMO Services Forecast
10.3.6 Australia Market Small Molecule Drug CDMO Services Forecast
10.4 Europe Small Molecule Drug CDMO Services Forecast by Country (2025-2030)
10.4.1 Germany Market Small Molecule Drug CDMO Services Forecast
10.4.2 France Market Small Molecule Drug CDMO Services Forecast
10.4.3 UK Market Small Molecule Drug CDMO Services Forecast
10.4.4 Italy Market Small Molecule Drug CDMO Services Forecast
10.4.5 Russia Market Small Molecule Drug CDMO Services Forecast
10.5 Middle East & Africa Small Molecule Drug CDMO Services Forecast by Region (2025-2030)
10.5.1 Egypt Market Small Molecule Drug CDMO Services Forecast
10.5.2 South Africa Market Small Molecule Drug CDMO Services Forecast
10.5.3 Israel Market Small Molecule Drug CDMO Services Forecast
10.5.4 Turkey Market Small Molecule Drug CDMO Services Forecast
10.6 Global Small Molecule Drug CDMO Services Forecast by Type (2025-2030)
10.7 Global Small Molecule Drug CDMO Services Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Small Molecule Drug CDMO Services Forecast
11 Key Players Analysis
11.1 Gliead
11.1.1 Gliead Company Information
11.1.2 Gliead Small Molecule Drug CDMO Services Product Offered
11.1.3 Gliead Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Gliead Main Business Overview
11.1.5 Gliead Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Small Molecule Drug CDMO Services Product Offered
11.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Vertex
11.3.1 Vertex Company Information
11.3.2 Vertex Small Molecule Drug CDMO Services Product Offered
11.3.3 Vertex Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Vertex Main Business Overview
11.3.5 Vertex Latest Developments
11.4 Mirati Therapeutics
11.4.1 Mirati Therapeutics Company Information
11.4.2 Mirati Therapeutics Small Molecule Drug CDMO Services Product Offered
11.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mirati Therapeutics Main Business Overview
11.4.5 Mirati Therapeutics Latest Developments
11.5 AMPAC
11.5.1 AMPAC Company Information
11.5.2 AMPAC Small Molecule Drug CDMO Services Product Offered
11.5.3 AMPAC Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AMPAC Main Business Overview
11.5.5 AMPAC Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Small Molecule Drug CDMO Services Product Offered
11.6.3 Pfizer Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Polypeptide
11.7.1 Polypeptide Company Information
11.7.2 Polypeptide Small Molecule Drug CDMO Services Product Offered
11.7.3 Polypeptide Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Polypeptide Main Business Overview
11.7.5 Polypeptide Latest Developments
11.8 Bachem
11.8.1 Bachem Company Information
11.8.2 Bachem Small Molecule Drug CDMO Services Product Offered
11.8.3 Bachem Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bachem Main Business Overview
11.8.5 Bachem Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Small Molecule Drug CDMO Services Product Offered
11.9.3 Merck Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Small Molecule Drug CDMO Services Product Offered
11.10.3 Asymchem Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Information
11.11.2 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Offered
11.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Main Business Overview
11.11.5 Thermo Fisher Scientific Latest Developments
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Information
11.12.2 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Offered
11.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview
11.12.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments
11.13 Porton Fine Chemicals
11.13.1 Porton Fine Chemicals Company Information
11.13.2 Porton Fine Chemicals Small Molecule Drug CDMO Services Product Offered
11.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Porton Fine Chemicals Main Business Overview
11.13.5 Porton Fine Chemicals Latest Developments
11.14 Lonza Group
11.14.1 Lonza Group Company Information
11.14.2 Lonza Group Small Molecule Drug CDMO Services Product Offered
11.14.3 Lonza Group Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lonza Group Main Business Overview
11.14.5 Lonza Group Latest Developments
11.15 JOINN Biologics
11.15.1 JOINN Biologics Company Information
11.15.2 JOINN Biologics Small Molecule Drug CDMO Services Product Offered
11.15.3 JOINN Biologics Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 JOINN Biologics Main Business Overview
11.15.5 JOINN Biologics Latest Developments
11.16 Zhejiang Langhua Pharmaceutical
11.16.1 Zhejiang Langhua Pharmaceutical Company Information
11.16.2 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Offered
11.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Zhejiang Langhua Pharmaceutical Main Business Overview
11.16.5 Zhejiang Langhua Pharmaceutical Latest Developments
11.17 Kingchem (Liaoning) Life Science
11.17.1 Kingchem (Liaoning) Life Science Company Information
11.17.2 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Offered
11.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Kingchem (Liaoning) Life Science Main Business Overview
11.17.5 Kingchem (Liaoning) Life Science Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-small-molecule-drug-cdmo-services-market-growth-status-and-outlook-2024-2030

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare